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Structural and functional modelling 
of SARS‑CoV‑2 entry in animal 
models
Greg n. Brooke1,2* & filippo prischi1,2*
SARS‑CoV‑2 is the novel coronavirus responsible for the outbreak of COVID‑19, a disease that has 
spread to over 100 countries and, as of the 26th July 2020, has infected over 16 million people. Despite 
the urgent need to find effective therapeutics, research on SARS‑CoV‑2 has been affected by a lack of 
suitable animal models. To facilitate the development of medical approaches and novel treatments, 
we compared the ACE2 receptor, and TMPRSS2 and Furin proteases usage of the SARS‑CoV‑2 Spike 
glycoprotein in human and in a panel of animal models, i.e. guinea pig, dog, cat, rat, rabbit, ferret, 
mouse, hamster and macaque. Here we showed that ACE2, but not TMPRSS2 or Furin, has a higher 
level of sequence variability in the Spike protein interaction surface, which greatly influences Spike 
protein binding mode. Using molecular docking simulations we compared the SARS‑CoV and SARS‑
CoV‑2 Spike proteins in complex with the ACE2 receptor and showed that the SARS‑CoV‑2 Spike 
glycoprotein is compatible to bind the human ACE2 with high specificity. In contrast, TMPRSS2 
and Furin are sufficiently similar in the considered hosts not to drive susceptibility differences. 
Computational analysis of binding modes and protein contacts indicates that macaque, ferrets and 
hamster are the most suitable models for the study of inhibitory antibodies and small molecules 
targeting the SARS‑CoV‑2 Spike protein interaction with ACE2. Since TMPRSS2 and Furin are similar 
across species, our data also suggest that transgenic animal models expressing human ACE2, such as 
the hACE2 transgenic mouse, are also likely to be useful models for studies investigating viral entry.
Coronaviruses are a large family of viruses that can cause respiratory diseases in humans. These can be mild, 
for example the common cold, but some coronaviruses have caused severe respiratory disease outbreaks in 
recent years. This family of viruses were found to be the cause of the 2002 Severe Acute Respiratory Syndrome 
(SARS coronavirus, SARS-CoV) and 2012 Middle East Respiratory Syndrome (MERS coronavirus, MERS-CoV) 
 outbreaks1. In December 2019, a novel coronavirus (SARS-CoV-2) was identified in Wuhan City of Hubei Prov-
ince (China) in patients that had developed viral pneumonia, called COVID-192.
SARS-CoV-2 is a positive-sense single-stranded RNA virus, that belongs to the β-coronaviruses family along 
with SARS and  MERS3. Sequencing of the genome of SARS-CoV-2 has demonstrated that it is closely related 
to coronaviruses isolated from bats. Indeed, these analyses have shown that the genome of SARS-CoV-2 has 
96.1% sequence similarity with SARSr-Ra-BatCoV-RaTG13, identified in Rhinolophus affinis bats captured in 
Pu’er (China) in  20132,4. For this reason, it has been proposed that bats have acted as an ecological reservoir for 
SARS-CoV-2. However, since humans have limited contact with bats, it is believed that SARS-CoV-2 passed 
through an intermediate host before spilling over into the human population. It remains unclear as to which 
species may have acted as the intermediate host. In the case of SARS, bats were also likely to have been the eco-
logical reservoir and farmed Civet cats were suggested to have been the intermediate species, although several 
studies have disputed  this5.
The SARS-CoV-2 genome contains five genes that code for four structural proteins—spike (S), envelope (E), 
membrane (M) and nucleocapsid (N)—and 16 non-structural  proteins6. Viral entry into human cells is mediated 
by an interaction between the S glycoprotein and the Angiotensin-Converting Enzyme 2 (ACE2)  receptor7. ACE2 
is a metalloprotease that lowers blood pressure by catalysing the hydrolyses of angiotensin  II8. However, ACE2 
enzymatic activity is not related, or needed, in SARS-CoV-2 entry into the host cells. Importantly, cells lacking 
ACE2 are not susceptible to SARS-CoV-2  infection9. Cryo–electron microscopy analysis of human ACE2 bound 
to the Receptor Binding Domain (RBD) of the SARS-CoV-2 S glycoprotein showed that ACE2 is a dimer that 
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interacts with two S protein  trimers10. Detailed structural data have also shown that the S protein binds human 
ACE2 with high affinity (~ 15 nM). This is 10–20 times higher than the affinity between the SARS-Cov S protein 
and ACE2, which likely explains the high infectivity of SARS-CoV-211.
Upon binding of the S protein to ACE2, the S protein goes through a conformational change that exposes a 
cleavage site between the S1 and the S2 domains, which is cleaved initially by Furin and then by the Transmem-
brane Serine Protease 2 (TMPRSS2)12–14. S2 is then further cleaved at the S2′ position which exposes the fusion 
peptide, promoting endocytic entry of the  virus15. Furin is an ubiquitously expressed type I transmembrane 
serine-protease, which has been intensely investigated for its roles in activation of substrates, bacterial and viral 
infections, as well as cancer and  metastasis16,17. The extracellular region of Furin contains a subtilisin-like cata-
lytic domain and a calcium-dependent regulatory P  domain18. The subtilisin-like domain contains the histidine, 
aspartate, and serine residues (the catalytic triad) necessary for enzymatic  activity18.
TMPRSS2 is a type II transmembrane serine proteases (TTSPs) which has been found to co-express, co-
localise and interact with  ACE214. TMPRSS2 belongs to the trypsin (S1) fold subfamily, which is characterised by 
a highly conserved catalytic serine protease domain stabilised by three intradomain disulphide bonds. Similarly 
to the Furin subtilisin-like domain, the peptidase S1 domain contains the catalytic triad necessary for enzymatic 
 activity19. Interestingly, studies on SARS-CoV have shown that the binding of the S protein to ACE2 also induces 
cleavage of ACE2 by TMPRSS2, and it has been suggested that the SARS-S-induced shedding of ACE2 may 
increase uptake of viral  particles20.
One of the major challenges for the study of SARS-CoV-2, and for the development of effective COVID-19 
vaccines and treatments, is the lack of appropriate animal models. Multiple animals have been shown to be 
experimentally susceptible to SARS-CoV (e.g. macaques, cats, ferrets, guinea pigs and civet cats)21–25. Similarly, 
SARS-CoV-2 has been shown to infect multiple animal species and a number of model systems have been pro-
posed for the study of COVID-1926. For example, Shi et al.27 found that SARS-CoV-2 can replicate in dogs, pigs, 
chicken and ducks, although viral replication in these animals is relatively weak. In contrast, the same group 
found that the virus can replicate efficiently in ferrets and cats.
It remains to be fully elucidated as to why infection rates differ between species, but structural differences 
in the viral entry receptors are likely to be important. Here we have used a combination of bioinformatics 
approaches to compare the binding of the SARS-CoV and SARS-CoV-2 S proteins to ACE2 and the structures 
of TMPRSS2 and Furin in a selected group of animal models; namely mouse, rat, guinea pig, rabbit, ferret, cat, 
dog hamster and macaque. Our results suggest that macaque, ferret and hamster represent the most promising 
animal models for the study of ACE2 inhibitors.
Methods
ACE2  structures preparation and docking.  The 3D structures of the SARS-CoV-2 and SARS-CoV 
RBD, in complex with human ACE2 (hACE2), were retrieved from the RCSB Protein Data Bank (PDB ID 6M17 
and 2AJF  respectively10,28). FASTA sequences were retrieved from NCBI (Table 1). ACE2 homology models were 
generated using Swiss  Model29 and the hACE2 structure as a template. GROMACS 2019.330 with AMBER99SB-
ILDN force field was used to resolve high energy intramolecular interaction and remove modelling biases before 
docking simulations. Structures were centred in a cubic box filled with TIP3P water molecules and counter ions. 
Simulations were run applying periodic boundary conditions. The energy of the system was minimised with 
10,000 steps using a steepest descent algorithm and equilibrated by running 100 ps of NVT (using V-rescale 
temperature coupling with tau-t of 0.1) and 100 ps NPT (applying Berendsen pressure coupling setting a tau-p 
of 0.5). ACE2 docking simulations with the RBD of the SARS-CoV-2 S glycoprotein were performed using the 
web server version of  HADDOCK31 (https ://haddo ck.scien ce.uu.nl). The docking simulations were driven using 
the binding interface derived from the RBD-ACE2 structures (PDB ID 6M17 and 2AJF) using  PDBePISA32. 
The structures of the RBD-ACE2 complexes are available on https ://githu b.com/fpris chi/Suppl ement ary_
Compl exesS truct ures. ACE2-RBD complexes structures were compared using PDBePISA, LigPlot + v2.2 and 
Table 1.  Summary of species included in the study. Species names and abbreviation list with corresponding 
NCBI accession codes for ACE2, TMPRSS2 and Furin.
Species Name ACE2 TMPRSS2 Furin
Homo sapiens Human hACE2 NP_001358344.1 hTMPRSS2 NP_005647.3 hFurin NP_002560.1
Cavia porcellus Guinea pig cavACE2 XP_023417808.1 cavTMPRSS2 XP_013001527.1 cavFurin XP_013014060.1
Canis lupus famil-
iaris Dog dogACE2 NP_001158732.1 dogTMPRSS2 XP_022268981.1 dogFurin XP_022272656.1
Felis catus Cat catACE2 XP_023104564.1 catTMPRSS2 XP_023094477.1 catFurin XP_023110662.1
Rattus norvegicus Rat ratACE2 NP_001012006.1 ratTMPRSS2 NP_569108.2 ratFurin XP_008757777.1
Oryctolagus 
cuniculus Rabbit rabACE2 XP_002719891.1 rabTMPRSS2 XP_008250697.1 rabFurin XP_002721548.2
Mustela putorius 
furo Ferret ferACE2 NP_001297119.1 ferTMPRSS2 XP_012916721.1 ferFurin XP_004763757.1
Mus musculus Mouse musACE2 NP_081562.2 musTMPRSS2 NP_056590.2 musFurin NP_035176.1
Cricetulus griseus Hamster hamACE2 XP_003503283.1 hamTMPRSS2 XP_027271516.1 hamFurin NP_001230915.1
Macaca fascicularis Macaque macACE2 XP_005593094.1 macTMPRSS2 XP_005548700.1 macFurin XP_005595531.1
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 PyMol33–35. ACE2 N-glycosylation sites were retrieved from  UniProt36. The electrostatic surface potential was 
calculated and visualised using the PyMol Adaptive Poisson-Boltzmann Solver (APBS) package (https ://pymol 
wiki.org/index .php/APBS). All structures were visualised, and relative figures prepared, using  PyMol35 (The 
PyMOL Molecular Graphics System; https ://www.pymol .org).
TMPRSS2 structures preparation.  TMPRSS2 FASTA sequences were retrieved from NCBI (Table 1). 
The human TMPRSS2 (hTMPRSS2) model was generated using I-TASSER37. The structures of TMPRSS2 are 
available on https ://githu b.com/fpris chi/Suppl ement ary_TMPRS S2. For consistency with the ACE2 models, 
the human structure that we modelled here was used as a template for homology modelling of TMPRSS2 for 
the other species using Swiss  Model29. Structures were compared, analysed and visualised using  PyMol35 (The 
PyMOL Molecular Graphics System; https ://www.pymol .org).
Furin sequence analysis.  Furin FASTA sequences were retrieved from NCBI (Table 1) and aligned using 
Clustal  Omega38.
Results
ACE2 interaction with the SARS‑Cov‑2 spike protein differs between species.  ACE2 is a zinc 
carboxypeptidase type I transmembrane protein, with an extracellular N-terminal peptidase domain (PD) and 
a cytosolic C-terminal collectrin-like domain (CLD) (Figure S1). The receptor binding domain (RBD) of the 
SARS-CoV-2 S protein binds directly to the ACE2 PD, and analysis of the crystal structure of this complex shows 
that the interaction is mostly driven by polar interactions (Table 2). Of particular interest are two key hydrogen 
bonds between ACE2 K31/E35 and S protein RBD Q493, the salt bridge between ACE2 D30 and RBD K417, and 
the hydrophobic interaction between ACE2 M82 and RBD F486 (Fig. 1A)28,39–41. Interestingly, Q493, K417 and 
F486 are not conserved between SARS-CoV and SARS-CoV-2, and these differences are linked to the higher 
affinity of the SARS-CoV-2 S protein for  ACE212. 
In order to predict if the SARS-CoV-2 S protein binds ACE2 of other animal species, focusing mostly on 
laboratory model systems, we generated homology models for cavACE2, dogACE2, catACE2, ratACE2, rabACE2, 
ferACE2, musACE2, hamACE2 and macACE2 (Table1). Alignment of the ACE2 sequences from these species, 
revealed a high conservation, with a sequence identity between 77.2% and 95.6% (Supplemental Figure S1-2). 
This allowed us to produce reliable ACE2 PD models via homology modelling using the hACE2 as a template. 
Importantly, before performing docking simulations, homology modelling biases were removed via molecular 
Table 2.  Residues forming direct interactions in the ACE2 PD – SARS-CoV-2 S protein RBD complexes. 
Residues forming contacts in the EM structure (PDB ID: 6M17) and in the HADDOCK docking models are 
listed by their position and by their single-letter identity, with the first residue belonging to ACE2 and the 
second to the S protein. Interactions were identified using PyMol and PDBePISA.
ACE2—RBD (PDB 6M17)
hACE-RBD cavACE2 dogACE2 catACE2 ratACE2 rabACE2 ferACE2 musACE2 hamACE2 macACE2
α1 
helix
α2 
helix β3-β4 loop
H-bond/
polar 
interac-
tions
Q24-
N487, 
T27-
Y489, 
K31-
Q493, 
H34-
Y453, 
E35-
Q493, 
E37-
Y505, 
D38-
Y449, 
Y41-
T500, 
Y41-
N501, 
Y41-
Q498
K353-G496, 
D355-T500, 
R357-T500
Q24-N487, 
T27-Y489, 
K31-Q493, 
H34-Y453, 
E35-Q493, 
E37-Y505, 
D38-Y449, 
Y41-T500, 
Y41-N501, 
Y41-Q498, 
K353-G496, 
D355-T500, 
R357-T500
Q24-N487, 
T27-Y489, 
E31-Q493, 
K34-Y453, 
D38-Y449, 
Y41-Q498, 
G352-Q498, 
K353-Y449, 
K353-Y495, 
K353-G496, 
K353-Q498, 
N354-T500, 
D355-T500, 
A386-Y505
T27-F456, 
K31-Q493, 
Y34-Y453, 
E35-S494, 
Y41-T500, 
Y41-N501, 
Q42-Y449, 
Y83-N487, 
Y83-Y489, 
E326-V503, 
N330-T500, 
K353-Y505, 
D355-T500, 
R357-T500
T27-Y473, 
T27-Y489, 
K31-Q493, 
H34-Y453, 
E35-Q493, 
E37-Y505, 
E38-Y449, 
Y41-Q498, 
Y83-N487, 
K355-N501, 
K355-G496, 
R395-Y505
K31-Q493, 
Q34-Y453, 
E35-Q493, 
D38-Y449, 
Y41-Q498, 
H353-Q498, 
D355-T500, 
A386-Y505
T27-Y489, 
K31-
Q493, 
E35-
Q493, 
D38-
Y449, 
E37-Y505, 
Y41-
Q498, 
Y41-T500,
T27-Y489, 
F28-Y489, 
K31-Q493, 
E35-Q493, 
E37-Y505, 
E38-Y449, 
Y41-T500, 
K353-Y495
T27-Y489, 
N30-K417, 
Q34-Y453, 
E35-Q493, 
E37-Y505, 
D38-Y449
Q24-N487, 
K31-Q493, 
Q34-Y453, 
E35-Q493, 
D38-Y449, 
K353-Y495, 
A386-Y505
Q24-G476, 
K31-Q493, 
E35-S494, 
E35-Q493, 
E37-Y505, 
D38-Y449, 
Y41-T500, 
Y83-N487, 
K353-G496
Salt 
bridge
D30-
K417 D30-K417
D30-K417, 
K35-E484 E30-K417 E30-K417
E26-K417, 
E37-R403, 
K387-D405
E30-K417 E30-K417 E30-K417 E30-K417
Hydro-
phobic
F28-
F486, 
F28-
Y489
L79-
F486, 
M82-
F486, 
Y83-
F486
F28-F486, 
F28-Y489, 
L79-F486, 
M82-F486, 
Y83-F486
L79-F486
L24-A475, 
L24-G476, 
Y83-F486
L24-A475, 
L24-G476, 
T82-F486
I79-F486
L24-A475, 
L24-G476, 
Y83-F486
F28-F486, 
L24-G476, 
L24-A475, 
L24-F456, 
Y34-Y453, 
Y34-L455, 
H79-F486, 
F83-F486
F28-Y489, 
S82-F486, 
F83-F486
L79-F486, 
N82-F486
T27-F456, 
F28-Y489, 
L79-F486, 
M82-F486
Suitable model system ✕ ✓ ✓ ✕ ✕ ✓ ✕ ✓ ✓
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dynamics equilibration. We then ran restrained docking simulations between the ACE2 PD models and the 
SARS-CoV-2 S protein RBD to generate optimised complexes. A docking simulation using hACE2 as a con-
trol was also performed (Fig. 1B). The presence of a similar network of interactions in the docking output for 
the hACE2 simulation compared to the one observed in the EM structure was used to validate the approach 
adopted (Table 2). Further validation of our approach comes from the RBD-macACE2 complex (Supplementary 
Figure S3). The level of sequence identity between hACE and macACE2 is 95.6% (Supplemental Figure S2) and 
our modelling show that the RBD-hACE2 and RBD macACE2 complexes are overall very similar, in line with 
experimental data showing that SARS-CoV-2 replication and shedding and disease symptoms are similar in 
human and  macaque42,43.
Overall the hydrophobic contributions that stabilise the RBD-ACE2 complex are similar in all models, with 
the ferACE2-RBD having a slightly higher number of hydrophobic contacts (Table 2 and Supplementary Fig-
ure S3). Interestingly, M82 in the hACE2 is not conserved across species (Supplemental Figure S1), and only 
Figure 1.  ACE2 PD – SARS-CoV-2 S protein RBD interaction surface. Cartoon representation of the trimeric 
SARS-CoV-2 S protein (PDB ID 6VSB) with the human ACE2 dimer (PDB ID 6M17), with the S protein in 
orange and the ACE2 in teal. In the close-up panels, the residues involved in direct interactions (see Table 2) 
are shown as sticks, with the SARS-CoV-2 RBD in orange and the ACE2 in teal (cryo-EM structure (A), human 
model (B), mouse model (C), rat model (D)). H-bonds, salt bridges and hydrophobic interactions are shown 
as yellow, red and purple dotted lines respectively. The Q498-H353 H-bond and K417-E26 slat bridge present 
only in the rat complex are shown with a yellow and red dotted line respectively. All structures are in the same 
orientation.
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the hACE2, hamACE2, macACE2, catACE2 and musACE2 form hydrophobic interaction between residue 82 
and the RBD F486 (Supplemental Figure S3). However, RBD F486 is in contact, in all complex structures, with a 
relatively hydrophobic patch formed by the ACE2 residues 28, 79 and 83 (Supplemental Figure S4A). Comparison 
of the surface electrostatic potentials of the ACE2 models identified a similar distribution of charges on the α1 
helix, α2 helix and β3-β4 loop across all species (Supplementary Figure S5).
Differences between the structure of hACE2 and musACE2 have been previously described to explain why 
SARS-CoV is a mild infection in  mice44. The most strikingly difference between the hACE2 and musACE2 are 
the D30 to N30 and K31 to N31 substitutions. This results in the lack of a salt bridge and a key H-bond in the 
musACE2-SARS-CoV-2 RBD complex (Table 2 and Fig. 1C). Specifically, the salt bridge with the K417 of the 
RBD seems to be a major driver of the interaction. In fact, similar to musACE2, ratACE2 has an Asn in position 
30, which prevents formation of a salt bridge with K417 in the RBD. However, E26 in the ratACE2 forms a salt 
bridge with K417, resulting in an altered complex structure with a shift of 6.5 Å of the RBD over the ratACE2, 
compared to its relative position in the human complex (Supplemental Figure S4B). This relative movement may 
also be driven by the substitution of K353 to H353, which in this new orientation interacts with Q498 (Fig. 1D). 
Importantly, previous data have shown that the K353H substitution substantially reduces SARS-CoV S protein 
binding to  hACE245.
The substitution of M82 to N82 in the ratACE2 and hamACE2 introduces an N-glycosylation  site45. The 
effects of this glycosylation may be different in rats and hamsters. In fact, due to the altered orientation of the 
rat complex, the glycosylation may create steric hindrance with F486 and N487, in line with experimental data 
showing that M82N reduces SARS-CoV S protein affinity for  ACE245. In contrast, our model suggests limited 
impact of this glycosylation on the RBD-hamACE2 complex formation, in agreement with experimental data 
showing that hamsters can be infected by SARS-CoV-2 and transmit the virus to other  hamsters46. However, 
experimental studies are needed to clarify the role of ACE2 glycosylation in these animal models.
Taken together, the differences in binding mode would suggest that mice and rat are unsuitable models for the 
study of COVID-19. Similarly, the presence of a salt bridge between K35 and E484 in the cavACE2-RBD complex 
(Supplemental Figure S3) would make guinea pig an unsuitable model for the study of inhibitory antibodies and 
small molecules targeting the ACE2 – SARS-CoV-2 S protein interaction.
SARS‑CoV S protein  in complex with ACE2.  In order to further validate the approach adopted we 
carried out docking simulations between SARS-CoV RBD, for which more experimental data are available, 
and hACE2, cavACE2, dogACE2, catACE2, ratACE2, rabACE2, ferACE2, musACE2, hamACE and macACE2. 
Indeed, comparison of the SARS-CoV and the SARS-CoV-2 RBD in complex with ACE2 shows that the two 
co-crystal structures are comparable (RMSD 2AJF) and the binding interfaces are similar (Table 3 and Fig. 2A). 
In line with previously published data, we see that the SARS-CoV S has a smaller interaction surface and a lower 
number of interactions with ACE2 compared to the SARS-CoV-2 S protein (Figs. 1A, 2A)47. 
Table 3.  List of residues forming direct interactions in the ACE2 PD–SARS-CoV S protein RBD complexes. 
Residues forming contacts in the crystal structure (PDB ID: 2AJF) and in the HADDOCK docking models 
are listed by their position and by their single-letter identity, with the first residue belonging to ACE2 and the 
second to the S protein. Interactions were identified using PyMol and PDBePISA.
ACE2–SARS-CoV RBD
ACE2—RBD 
(PDB 2AJF) hACE-RBD cavACE2 dogACE2 catACE2 ratACE2 rabACE2 ferACE2 musACE2 hamACE2 macACE2
H-bond/
polar inter-
actions
Q24-N473, 
T27-Y475, 
E37-Y491, 
D38-Y436, 
Y41-T486, 
Y41-T487, 
Q42-Y436, 
Y83-N473, 
N330-T486, 
K353-G488
Q24-N473, 
T27-Y475, 
E37-Y491, 
D38-Y436, 
Y41-T486, 
Y41-T487, 
Q42-Y436, 
Y83-N473, 
N330-T486, 
K353-G488
Q24-N473, 
Q24-D463, 
E37-Y491, 
D38-Y436, 
Y41-T486, 
Y41-T487, 
Y83-N473, 
K353-T486, 
K353-T486
E38-Y436, 
Y41-T486, 
N330-T486
E37-Y491, 
E38-T484, 
Y83-N473, 
K355-G488
K24-N473, 
S27-Y475, 
K31-Y442, 
K31-N479, 
E35-N479, 
D38-Y436, 
Y41-T486, 
H353-G488
L24-N473, 
K31-Y442, 
K31-N479, 
E37-Y491, 
Y83-Y475, 
Y83-N473, 
K353-G488
L24-N473, 
K31-Y442, 
E35-N479, 
E37-Y491, 
E38-Y436, 
Y41-T486, 
Y83-N473, 
K353-G488
N24-N473, 
N34-Y440, 
E35-N479, 
E37-Y491, 
D38-Y436, 
H353-G488
T27-Y475, 
Q34-Y440, 
E37-Y491, 
Y83-N473, 
K353-Y481, 
K353-G482, 
K353-G488
Q24-N473, 
K31-N479, 
E35-N479, 
E37-Y491, 
D38-Y436, 
Y83-N473, 
K353-Y481, 
K353-G482, 
K353-G488
Salt bridge E329-R426 E329-R426 E326-R426 E331-R426 K24-D463 E329-R426 E329-R426
Hydrophobic
F28-Y475, 
Y41-Y484, 
L45-Y484, 
L79-L472, 
M82-L472, 
K353-Y491
F28-Y475, 
Y41-Y484, 
L45-Y484, 
L79-L472, 
M82-L472, 
K353-Y491
F28-Y475, 
L34-Y440, 
L34-Y442, 
Y41-Y484, 
K353-Y491
L24-P462, 
L24-D463, 
F28-Y475, 
F28-N473, 
K31-Y475, 
Y34-Y440, 
Y34-Y442, 
Y41-Y484, 
L45-Y484, 
K353-Y491
L24-P462, 
L24-D463, 
F28-Y475, 
K31-Y475, 
H34-Y442, 
Y41-Y484, 
L79-L472
F28-Y475, 
Q34-Y440, 
Y41-Y484, 
H353-Y491, 
H353-Y484
L24-D463, 
L24-P462, 
T27-F460, 
T27-L443, 
F28-Y475, 
Y41-Y484, 
Y41-T487, 
L45-Y484, 
L79-L472, 
T82-L472, 
K353-Y491, 
K353-T487
F28-Y475, 
T27-F460, 
T27-L443, 
Y34-Y440, 
Y41-Y484, 
H79-L472, 
T82-L472, 
K353-Y491, 
K353-T487
N24-P462, 
T27, L443, 
T27-F460, 
F28-Y475, 
L45-Y484, 
Y41-Y484, 
T79-L472, 
H353-Y491, 
H353-T487
F28-Y475, 
Y41-Y484, 
L79-L472, 
K353-Y491
T27-F460, 
F28-Y475, 
Y41-Y484, 
L79-L472, 
K353-Y491
Can be infected Yes Yes49 / Yes23 No/yes28 / Yes23 Yes28 Yes50 Yes63
Present symptoms Yes Yes49 / No/mild23 No49 / Yes23 No/mild28 Yes50 Yes63
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The mode of binding of SARS-CoV RBD to hACE2 has several differences compared to that of the other 
ACE2 proteins analysed. While the binding of RBD to hACE2 is driven by polar interactions, similarly to 
what we observed for SARS-CoV-2, in all other SARS-CoV RBD-ACE2 models there are fewer H-bonds and 
a concomitant increase in hydrophobic interactions. Importantly, the substitution H34 to Y/L34 introduces a 
steric interference, which results in a shift of ~ 3 Å of the CR1 loop of  RBD48 bound to the dogACE2 and the 
cavACE2, compared to its relative position in the human complex (Supplementary Figure S6A, B). Similarly, the 
substitution of E329 with T/A/G/Q/K329 prevents the formation of a salt bridge with R426, and in the cavACE2 
complex creates a charge repulsion (Supplementary Figure S6C). Overall, this would suggest a lower affinity of 
the SARS-CoV RBD for the cavACE2, dogACE2, catACE2, ratACE2, rabACE2, ferACE2, musACE2, hamACE2 
in line with previously published data showing different susceptibility to infection of animal  models49. Indeed, 
SARS-CoV infection in cats, ferrets, mice, guinea pigs, and rats is weaker and does not replicate the human 
disease in all its  aspects49.
The interaction pattern of SARS-CoV with ferACE2 and hamACE2 is overall comparable to that of macACE 
and hACE2 (Fig. 2B–E). This is in line with experimental findings showing that hamsters support virus replication 
in the respiratory tract, have pronounced pathological findings in acute infection, but do not present  symptoms50. 
Similarly, virus replication and pneumonitis were observed in ferrets infected with SARS-CoV. Ferrets do not 
develop fever, but presented pulmonary lesions similar, but milder, to  macaques23. These milder symptoms in 
hamsters and ferrets could be linked to the missing E329-R426 bond present in human and macaque. In the 
same study, the authors reported even milder lesions in cats. This is in agreement with our data showing differ-
ences in the interaction pattern between the RBD and the hACE2 and catACE2 with a reduction in H-bonds23. 
Taken together our approach may provide a rationale for the observed experimental differences of the infection 
in human and animal models.
Figure 2.  ACE2 PD – SARS-CoV S protein RBD interaction surface. Cartoon representation of the of the 
interaction surface of SARS-CoV RBD with ACE2 in the (A) X-RAY structure (PDB ID 2AJF), (B) human 
model, (C) macaque model, (D) hamster model and (E) ferret model. The residues involved in direct 
interactions (see Table 3) are shown as sticks, with the SARS-CoV RBD in pink and the ACE2 in teal. All 
structures are in the same orientation.
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Figure 3.  The TMPRSS2 active site is highly conserved among species. (A) Cartoon representation of 
hTMPRSS2, with the SRCR domain in beige and the Peptidase S1 domain in teal. In the close-up panels the 
catalytic triad (H296, D345 and S441) is shown in violet sticks and molecular surface colored by electrostatic 
potential (from − 44 kT/e (red) to 44 kT/e (blue)). A pink dotted line has been placed in the Peptidase S1 
active pocket. (B) Multiple sequences alignment of hTMPRSS2, cavTMPRSS2, dogTMPRSS2, catTMPRSS2, 
ratTMPRSS2, rabTMPRSS2, ferTMPRSS2, musTMPRSS2. Peptidase S1 active pocket residues have been 
highlighted in red with the relative consensus sequence. Catalytic triad residues are shown in red in the 
consensus sequence.
8Vol:.(1234567890)
Scientific RepoRtS |        (2020) 10:15917  | https://doi.org/10.1038/s41598-020-72528-z
www.nature.com/scientificreports/
TMPRSS2 and Furin are highly conserved across species.  TMPRSS2 is a type II transmembrane 
serine protease (TTSPs), with an extracellular region composed of a low-density lipoprotein (LDL) receptor 
class A domain, a scavenger receptor cysteine-rich (SRCR) domain and a peptidase S1 domain containing the 
catalytic triad (Supplemental Figure S7). TMPRSS2, similar to other TTSPs, has high affinity towards substrates 
containing an Arg residue in the P1 position. Indeed, TMPRSS2 can recognise the SPRRAR/SVASQS and SKP-
SKR/SFIEDL sequences in the SARS-CoV-2 S glycoprotein and cleaves S1 from S2 between residues 685/686 
and further cleaves S2 between residues 815/816, resulting in the formation of S2′51.
In order to predict if TMPRSS2 from other animal species can cleave the SARS-CoV-2 S protein, the extra-
cellular domain sequences of hTMPRSS2, cavTMPRSS2, dogTMPRSS2, catTMPRSS2, ratTMPRSS2, rabTM-
PRSS2, ferTMPRSS2 and musTMPRSS2 were aligned. The alignment revealed high conservation with a sequence 
identity between 75.11% and 83.97% (Supplemental Figure S2). We then generated a model for hTMPRSS2 
(Fig. 3A and Figure S7) using I-TASSER, since classic homology modelling failed to identify a reliable template. 
The best I-TASSER output had a C-score of -0.52 with a TM-score of 0.65 ± 0.13 and an RMSD of 7.9 ± 4.4 Å. 
The model has the three conserved disulphide bonds on the peptidase S1 domain, characteristic feature of all 
TTSPs, between residues C281-C297, C410-C426 and C437-C46552. Disulphide bonds are also present between 
C113-C126, C120-C139, C133-C148, C172-C231 and C185-C241, which further validates the reliability of the 
models generated (Fig. 3A and S7).
The pocket containing the catalytic triad has a uniform negative charge, which favours electrostatic interac-
tions with the Arg reach peptide of the S protein (Fig. 3A). Using this structural information, we identified the 
residues surrounding the catalytic triad that form a pocket on the head of TMPRSS2. Interestingly, this pocket 
is identical in all species studied and no substantial differences from the hTMPRSS2 were observed (Fig. 3B).
In addition to TMPRSS2, the protease Furin has also been shown to be involved in SARS-CoV-2 S protein 
cleavage at the S1/S2  site12,13. The S protein is initially cleaved by Furin and is then further processed by TMPRSS2 
and so both proteases appear to be indispensable in viral  entry13. We therefore also compared the well character-
ised substrate-binding residues of  Furin17 across species. Similarly to TMPRSS2, Furin is highly conserved across 
species (94–98.9% similar to human, Figure S2). Further, the substrate-binding cleft is identical in all species 
studied (Supplementary Figure S8). Taken together these data suggest that TMPRSS2 and Furin of all species 
studied can cleave the SARS-CoV-2 S glycoprotein in a similar way to hTMPRSS2.
Discussion
The rate at which new infectious diseases are discovered has dramatically increased in the last 20 years53. Most 
of the new viral infections are caused by viruses belonging to well-characterised virus families, like the novel 
coronavirus SARS-CoV-21. SARS-CoV-2 was identified in December 2019 to be the viral agent causing COVID-
19, which has now spread to over 100  countries1. As a result, there is a global priority to identify and develop 
effective vaccines and drugs for the treatment of the disease. However, this effort is in part being hampered by 
the lack of suitable animal  models27. Ideal animal models should be infected in a similar way to humans, present 
comparable symptoms, present a correlation between disease severity and virus titer, have similar histopathologic 
changes, virus growth kinetics, and comparable levels of  mortality54.
Coronaviruses are characterised by the presence of the S glycoprotein on the viral surface, which confer a 
unique crown-like morphology to the  virion55. The S protein mediates both the attachment to the host cell and 
the fusion with the cell  membranes7. As such, the S protein is the key element that determines cell tropism and 
the host  range56. For cellular entry, the S protein binds to ACE2 and is primed by TMPRSS2, which promotes 
endocytic entry of the  virus15. Importantly, ACE2 and TMPRSS2 appear to be widely expressed across mammals. 
Lung transcriptomic data is not available for all of the species investigated in this study. However, investigation 
of expression data for Macaca mulatta, Rattus norvegicus, Mus musculus, Canis lupus familiaris and Oryctolagus 
cuniculus demonstrated that ACE2 and TMPRSS2 are detectable in the lungs of these species (Expression  Atlas57 
and  Bgee58). Further, these receptors were also found to be expressed in the lungs of multiple other animal species 
(e.g. Bos taurus, Macaca mulatta, Ovis aries and Papio Anubis).
An increasing body of evidence suggests that the tight binding of the S protein to ACE2 is the reason for the 
high person-to-person transmission rates and severity associated with this  disease11,12,45. This is most evident 
when comparing the SARS 2002–2004 pandemic with the SARS-CoV-2 pandemic, with 8,098 cases versus over 
16 million cases (26th July 2020) respectively. Our analysis demonstrated that the SARS-CoV and SARS-CoV-2 
S proteins have substantial differences in their ACE2 binding motifs (50% identity), which results in an increased 
number of contacts between the SARS-CoV-2 S protein and ACE2. This correlates with the observed 10- to 
20-fold higher affinity of the SARS-CoV-2 S protein for ACE2, compared to SARS-CoV S  protein11.
It is clear that SARS-CoV-2 infection rates differ between species, and this is linked to the ability of the S pro-
tein to exploit ACE2 and proteases to enter the host  cell56. Transfection of HELA cells with ACE2 from different 
species (human, Chinese horseshoe bat, civet, pig and mouse) demonstrated that the receptor from all species 
could be used for entry, except for  mouse2. Further, Hoffman et al. used pseudotyped virus to demonstrate that 
SARS-CoV-2 can enter human and African green monkey cell lines and to a lesser extent dog and bat lines. In 
contrast, the virus was found to be unable to infect pig, cow, hamster and mouse  lines59. The demonstration that 
SARS-CoV-2 is unable to utilise the mouse ACE2 for entry, correlates with our findings that demonstrates that 
key residues in the interaction surface differ between musACE2 and hACE2. The results presented here would 
suggest that SARS-CoV-2 can interact with hamACE2 and hence it is surprising that Hoffman et al. found that 
the pseudotyped virus was unable to enter hamster  cells59. However, in agreement with our findings, Sia et al. 
have shown that golden hamster is a suitable in vivo model for the study of SARS-CoV-2, with the symptoms 
resembling a mild infection in  humans46.
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Our results show that the Spike protein recognises macaque, hamster, and ferret in a comparable way to 
human ACE2, in line with data showing high susceptibility of these animals to SARS-CoV-2  infection27,46. In 
contrast, we saw substantial differences in the binding mode of the SARS-CoV and SARS-CoV-2 S protein to 
guinea pigs, mice and rats ACE2. For example, guinea pigs can be infected with SARS-CoV49 (no data available 
for SARS-CoV-2) and we report that although SARS-CoV-2 S protein can bind guinea pig ACE2 (cavACE2), the 
mode of binding differs to hACE2. In fact, compared to the human protein, the RBD-cavACE2 complex has a 
reduction of four direct hydrophobic contacts, which reduces protein  affinity60 and a concomitant extra charge 
reinforced hydrogen bond, which stabilises protein  binding25. This results in a difference in binding kinetics 
between the RBD-cavACE2 and the RBD-hACE2. The different types of interaction stabilising the complexes are 
also likely to affect the ability of Protein–Protein Interaction (PPI) inhibitors to modulate, in a comparable way, 
the binding of RBD to hACE and cavACE. Therefore, while guinea pigs could be useful models for e.g. toxicity 
studies, they are unlikely to be suitable for the testing of inhibitory antibodies and small molecules targeting the 
ACE2 – S protein interaction surface.
Unlike ACE2, TMPRSS2 and Furin are highly conserved across the species analysed. Modelling of TMPRSS2 
demonstrated that the catalytic triad (residues H296, D345 and S441 in hTMPRSS2) forms a negatively charged 
pocket, which favours electrostatic interactions with the positive charged peptides of the S protein. This region 
was found to be identical in all species analysed and it therefore appears that differences in infectivity across 
species is unlikely to be due to structural differences in TMPRSS2. Similarly to what we saw for TMPRSS2, Furin 
is highly conserved across species, with a sequence similarity of 95–98.9% compared to the hFurin. The identical 
Furin substrate-binding cleft also suggests a similar activity of the protease in all species analysed.
This study suggests that the macaque, hamster and ferret are currently the most suitable models for studies 
that aim to target the ACE2 – S protein interaction. Previous studies found SARS-CoV to be mildly infective in 
mice compared to humans and this was suggested to be as a result of differences between the structure of hACE2 
and  musACE244. Importantly, transgenic expression of hACE2 in mice (K18-hACE2 Mice) resulted in SARS-
CoV becoming a rapidly fatal disease in this  model61. Similarly, Bao et al. demonstrated that hACE2 transgenic 
mice are susceptible to SARS-CoV-2, unlike wild-type mice, and the infection resembles aspects of the human 
 disease62. The hACE2 mouse is therefore also a suitable model for SARS-CoV-2 studies. This also supports the 
findings of this study, which suggests that the high level of TMPRSS2 similarity between species does not appear 
to affect viral entry, but instead it is the species-specific differences in the structure of ACE2 that affects SARS-
CoV and SARS-CoV-2 infectivity. Due to the similarities in TMPRSS2 and Furin between species, studies that 
aim to target these proteases have a range of suitable models available.
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